Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure
β Scribed by David R. Powell; Frances Liu; Bonita K. Baker; Phillip D. K. Lee; Raymond L. Hintz
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 640 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
endocrine fashion, and their bioactivity is greatly modulated Hyperinsulinemic euglycemic clamps were performed by their binding proteins. Thus, GH, which reduces sensitivon six patients with compensated alcoholic cirrhosis and ity to insulin, normally stimulates the secretion of IGF-I, on six norma
Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b
## Abstract The IGF/IGFβIR system plays a major role in the pathogenesis and progression of Ewing's sarcoma. In this article, the authors evaluated whether the insulinβlike growth factor binding proteinβ3 (IGFBPβ3), a molecule with growthβinhibitory and proapoptotic activities, may be exploited for
The insulin-like growth factors (IGFs) have been implicated in the growth regulation of human breast cancer. Since the lCFs are associated with specific binding proteins (ICFBPs) which may modulate receptor/ligand interactions, production of IGFBPs by breast cancer cells could alter their IGF-depend